Healthcare // Analytics
News
1/20/2011
02:42 PM
Connect Directly
RSS
E-Mail
50%
50%

FDA Revamps Medical Device Approval

The 510(k) program overhaul aims to facilitate innovation, streamline the review process, and protect patient safety.

Health IT Boosts Patient Care, Safety
(click image for larger view)
Slideshow: Health IT Boosts Patient Care, Safety

The Food and Drug Administration unveiled Wednesday a plan to revamp its 510(k) program that medical device manufacturers use to clear their products before they can be marketed and sold to the public.

Many medical device manufacturers see the efficient running of the 510(k) program as pivotal to stimulating U.S. innovation, investment, and job growth in the medical device industry. The FDA's Center for Devices and Radiological Health (CDRH) uses the program to clear some 3,000 new medical devices for patients each year.

"Facilitating innovation is a critical part of the agency's responsibility to promote the public health, but this can happen only if the U.S. can support a robust, innovative, medical device industry," Jeffrey Shuren, director of FDA's center for devices and radiological health, said in a statement. "The steps we are announcing today remove roadblocks to innovation while protecting patient safety."

To facilitate innovation in medical devices, the FDA will:

-- Streamline the review process for innovative, lower-risk products, called the "de novo" process;

-- Publish guidance for industry to clarify when clinical data should be submitted to increase predictability and transparency;

-- Develop a network of external experts who can use their knowledge and experience to help the agency address important scientific issues regarding new medical device technologies; and

-- Establish a new Center Science Council of senior FDA experts within the agency's medical device center to assure more timely and consistent science-based decision making.

The FDA also announced that it will strengthen its capacity to examine and monitor the safety of medical devices once they are on the market and being used. It will establish a public database of important device information, such as medical device labeling and summaries of the basis for the FDA's decision to clear specific devices. It will also require a brief description of scientific information regarding the safety and effectiveness known to the manufacturer for select higher-risk devices on a case-by-case basis through device-specific guidance.

Previous
1 of 2
Next
Comment  | 
Print  | 
More Insights
Big Love for Big Data? The Remedy for Healthcare Quality Improvements
Big Love for Big Data? The Remedy for Healthcare Quality Improvements
Healthcare data is nothing new, but yet, why do healthcare improvements from quantifiable data seem almost rare today? Healthcare administrators have a wealth of data accessible to them but aren't sure how much of that data is usable or even correct.
Register for InformationWeek Newsletters
White Papers
Current Issue
InformationWeek Must Reads Oct. 21, 2014
InformationWeek's new Must Reads is a compendium of our best recent coverage of digital strategy. Learn why you should learn to embrace DevOps, how to avoid roadblocks for digital projects, what the five steps to API management are, and more.
Video
Slideshows
Twitter Feed
InformationWeek Radio
Archived InformationWeek Radio
A roundup of the top stories and trends on InformationWeek.com
Sponsored Live Streaming Video
Everything You've Been Told About Mobility Is Wrong
Attend this video symposium with Sean Wisdom, Global Director of Mobility Solutions, and learn about how you can harness powerful new products to mobilize your business potential.